![Immunohistochemistry: SLMO2 Antibody [21990002] - Both normal and cancer tissues displayed distinct cytoplasmic staining of macrophages and in a subset of inflammatory cells. Most other normal tissues exhibited weak to moderate cytoplasmic positivity. Squamous epithelia, myocytes and cells of the CNS were negative. Among cancers, few cases of colorectal, endometrial, ovarian, thyroid and pancreatic carcinomas showed weak to moderate staining. Hepatocellular carcinomas were also mainly weak to moderate while cholangiocarcinomas were negative. A single case of hepatocellular carcinomas exhibited strong cytoplasmic and nuclear positivity. Most other tumors were negative. Image and statement courtesy of the Human Protein Atlas (HPA).](http://www.bioprodhub.com/system/product_images/ab_products/5/sub_9/15322_21990002=IHC_Courtesy_of_HPA.jpg)
Immunohistochemistry: SLMO2 Antibody [21990002] - Both normal and cancer tissues displayed distinct cytoplasmic staining of macrophages and in a subset of inflammatory cells. Most other normal tissues exhibited weak to moderate cytoplasmic positivity. Squamous epithelia, myocytes and cells of the CNS were negative. Among cancers, few cases of colorectal, endometrial, ovarian, thyroid and pancreatic carcinomas showed weak to moderate staining. Hepatocellular carcinomas were also mainly weak to moderate while cholangiocarcinomas were negative. A single case of hepatocellular carcinomas exhibited strong cytoplasmic and nuclear positivity. Most other tumors were negative. Image and statement courtesy of the Human Protein Atlas (HPA).
![ELISA: SLMO2 Antibody [21990002]](http://www.bioprodhub.com/system/product_images/ab_products/5/sub_9/15323_21990002-614A1.jpg)
ELISA: SLMO2 Antibody [21990002]